EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Piezo-Type Mechanosensitive Ion Channel Component 1 (PIEZO1) as a Potential Prognostic Marker in Renal Clear Cell Carcinoma

Paulina Antosik iD, Martyna Szachniewicz, Michał Baran iD, Klaudia Bonowicz iD, Dominika Jerka iD, Ewelina Motylewska iD, Maciej Kwiatkowski, Maciej Gagat iD, Dariusz Grzanka iD

International Journal of Molecular Sciences · 09.07.2025 · 26 (14) · 6598

DOI: 10.3390/ijms26146598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.07.2025. Verfasst von Paulina Antosik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-094 Bydgoszc…. Hauptthemen laut MEDLINE: Ion Channels, Carcinoma, Renal Cell, Biomarkers, Tumor, Kidney Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nicolaus Copernicus University in Torun.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of kidney cancer and is often diagnosed at advanced stages. PIEZO1, a mechanosensitive ion channel, has been implicated in cancer progression, but its prognostic relevance in ccRCC remains unclear. This study aimed to evaluate the expression pattern of PIEZO1 in ccRCC and its association with clinicopathological characteristics and patient survival. Immunohistochemical analysis was performed on formalin-fixed, paraffin-embedded tumor tissues from 111 patients with ccRCC, along with 23 matched peritumoral non-cancerous tissues. Protein expression was quantified using the H-score system. Associations with tumor grade, staging, and overall survival (OS) were analyzed. mRNA expression data were retrieved from The Cancer Genome Atlas (TCGA) to validate the protein-level findings. Functional enrichment and pathway analyses were conducted to explore the biological context of PIEZO1-related gene expression. PIEZO1 showed predominantly cytoplasmic localization, with significantly lower expression in tumor tissues compared to adjacent non-malignant tissue (p < 0.0001). High PIEZO1 expression was correlated with higher tumor grade (p = 0.0147) and shorter OS (p = 0.0047). These findings were confirmed at the mRNA level in the TCGA cohort. Multivariate Cox regression analysis identified PIEZO1 as an independent prognostic factor for OS. In conclusion, PIEZO1 may serve as a clinically relevant biomarker in ccRCC. Its overexpression is associated with more aggressive tumor characteristics and poor prognosis, underscoring the need for further investigation into its functional role and potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ion ChannelsCarcinoma, Renal CellBiomarkers, TumorKidney NeoplasmsHumansFemaleMalePrognosisMiddle AgedAgedGene Expression Regulation, NeoplasticAdult

Stichwörter der Autor:innen

PIEZO1prognostic factorrenal clear cell carcinoma

Substanzen

Ion ChannelsPIEZO1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-094 Bydgoszcz, Poland.
  • Department of Histology and Embryology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-092 Bydgoszcz, Poland.
  • Department of Morphological and Physiological Sciences, Faculty of Medicine, Collegium Medicum, Mazovian Academy in Płock, 09-402 Płock, Poland.
  • Department of Immunoendocrinology, Chair of Endocrinology, Medical University of Lodz, 92-213 Lodz, Poland.
  • Department of Urology and Urological Oncology, Multidisciplinary Hospital of Ludwik Blażek, 88-100 Inowrocław, Poland.

ORCID-Profile: Paulina Antosik, Michał Baran, Klaudia Bonowicz, Dominika Jerka, Ewelina Motylewska, Maciej Gagat, Dariusz Grzanka

Förderung

  • Nicolaus Copernicus University in Torun

Zitieren

APA

Antosik, P., Szachniewicz, M., Baran, M., Bonowicz, K., Jerka, D., Motylewska, E., Kwiatkowski, M., Gagat, M., & Grzanka, D. (2025). Piezo-Type Mechanosensitive Ion Channel Component 1 (PIEZO1) as a Potential Prognostic Marker in Renal Clear Cell Carcinoma. International Journal of Molecular Sciences, 26(14), 6598. https://doi.org/10.3390/ijms26146598

Vancouver

Antosik P, Szachniewicz M, Baran M, Bonowicz K, Jerka D, Motylewska E, et al. Piezo-Type Mechanosensitive Ion Channel Component 1 (PIEZO1) as a Potential Prognostic Marker in Renal Clear Cell Carcinoma. International Journal of Molecular Sciences. 2025;26(14):6598. doi:10.3390/ijms26146598

BibTeX
@article{Antosik2025,
  author = {Antosik, Paulina and Szachniewicz, Martyna and Baran, Michał and Bonowicz, Klaudia and Jerka, Dominika and Motylewska, Ewelina and Kwiatkowski, Maciej and Gagat, Maciej and Grzanka, Dariusz},
  title = {Piezo-Type Mechanosensitive Ion Channel Component 1 (PIEZO1) as a Potential Prognostic Marker in Renal Clear Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6598},
  doi = {10.3390/ijms26146598}
}
Kostenlos starten →